Voll Non-Degradable Shoulder Spacer FIH Study

Starting soon · Not applicable

Conditions studied: Massive Rotator Cuff Tears, Massive Rotator Cuff Tear

In brief

The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).

Key facts

Study ID

NCT07745647

Run by

Voll Medical Technologies Ltd.

People needed

10

Starts

2026-09-01

Expected to finish

2028-09-01

Last updated by the study team

2026-08-04

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Full thickness MRCT.
• Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.

You may not qualify if…

• Documented evidence of a history of drug/alcohol abuse within 1 year of enrollment.
• Concurrent participation in any other investigational clinical study.

Where it is running

• Assuta Ashdod Hospital — Ashdod, Israel

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.